JohnnyInvesting's Profile
Displaying 1-11 of 11 result(s).
Recent Articles
- Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
- Kering Partners with L'Oréal to Transform Luxury Beauty Sector
- Alice Walton and Elon Musk: Giants of Wealth in 2025
- Clarins and V Magazine Host a Glamorous Golden Hour Event
- Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
- Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
- Exploring NB HASH and the Transformation of Wealth Today
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors
- Solidarity in Aviation: Airline Workers Support Controllers
- Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
- Promising Outcomes Unveiled from HARMONi-6 Clinical Study
- Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
- Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
- Promising Findings on Subcutaneous Amivantamab for Cancer
- Vivace Therapeutics Reports Promising Results for VT3989 Therapy
- iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
- Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
- New Breakthrough Data from Novartis on Prostate Cancer Treatment
- Transforming Assets: The Role of NB HASH in Digital Wealth
- The Future of Wealth: Bridging Real-World Assets with Blockchain
- Avacta Therapeutics Reveals Promising Phase 1a Results for FAP-Dox
- Significant Phase 1a Trial Findings for Faridoxorubicin
- Major Developments in AI: Insights from Top Tech Executives
- Celebrating Five Years of Innovations at United Imaging's Hub
- International Engagement Highlighted at Financial Forum 2025
- Crypto World Buzzes: Ripple's Fund, Bitcoin's Future & More
- Max Stock Limited Reveals Holdings of Key Parties and Officers
- China's Revolutionary Advances in Solid-State Battery Tech
- Biggest Weekly Losers: Insights on IonQ and Tempus AI Stocks
- Revolutionizing Startup Insight with AI: Startuprad.io's New Tool
- Revolutionizing Patient Care with AI: HDAI's Innovative Approach
- Top Gainers in the Market: D-Wave, Estée Lauder & Others
- Empowering Higher Education Payroll Professionals at EIPC
- SystImmune's Iza-bren Shows Promising Results in Cancer Trial
- Latest Developments in the Auto Industry and Technology Advancements
- RAPT Therapeutics Set to Unveil Key Clinical Findings Soon
- Tech Industry Update: Innovations, Earnings, and Future Trends
- Mutuum Finance Advances Plans for Testnet Launch in 2025
- Replimune Showcases Promising Results for Acral Melanoma
- Exciting Developments in RAPT Therapeutics' Clinical Trials
